Cargando…
Role of N(6)-methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)
Pancreatic cancer (PC) ranks as the seventh leading cause of cancer-associated mortality, and is predicted to become the third leading cause of cancer-associated mortality by the year 2025. Although advanced modalities of diagnosis and treatment have been continuously emerging, the mortality rate (4...
Autores principales: | Ye, Tong, Wang, Jiaxin, Zhao, Haiying, Zhao, Guiping, Li, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699722/ https://www.ncbi.nlm.nih.gov/pubmed/36367195 http://dx.doi.org/10.3892/ijo.2022.5452 |
Ejemplares similares
-
N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer
por: Ma, Mingyang, et al.
Publicado: (2022) -
The potential role of RNA N6-methyladenosine in primary Sjögren’s syndrome
por: Xiao, Qiufeng, et al.
Publicado: (2022) -
Corrigendum: The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome
por: Xiao, Qiufeng, et al.
Publicado: (2023) -
Research advances of N6‐methyladenosine in diagnosis and therapy of pancreatic cancer
por: Chen, Sai, et al.
Publicado: (2022) -
The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)